Cargando…

Diagnostic significance of urinary long non-coding PCA3 RNA in prostate cancer

Prostate cancer antigen 3(PCA3) is a long non-coding RNA, which was found increased expression in CaP patients than healthy individual. In this study, the individual nucleic acid of PCA3 and PSA was recombinant expressed as a reference reagent, and a quantitative RT-PCR with TaqMan assay was develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tao, Qu, Xiangyun, Jiang, Jiajia, Gao, Peng, Zhao, Dingding, Lian, Xueqi, Li, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601676/ https://www.ncbi.nlm.nih.gov/pubmed/28938580 http://dx.doi.org/10.18632/oncotarget.17272

Ejemplares similares

Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men
por: Opoku Mensah, Bismark, et al.
Publicado: (2022)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021)

A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness
por: Lai, John, et al.
Publicado: (2017)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)

Consequences of PCA graphs, SNP codings, and PCA variants for elucidating population structure
por: Gauch, Hugh G., et al.
Publicado: (2019)

The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer
por: Lemos, Ana Emília Goulart, et al.
Publicado: (2019)

Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer
por: Chunhua, Lin, et al.
Publicado: (2018)

PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples
por: Kotova, Elena S, et al.
Publicado: (2020)

Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer
por: Mao, Zujie, et al.
Publicado: (2018)

Urinary PCA3 detection in prostate cancer by magnetic nanoparticles coupled with colorimetric enzyme-linked oligonucleotide assay
por: Yamkamon, Vichanan, et al.
Publicado: (2020)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
por: Ferro, Matteo, et al.
Publicado: (2017)

The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells
por: Cheng, Huiying, et al.
Publicado: (2021)

Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
por: Tallon, Lucile, et al.
Publicado: (2014)

The expression and significance of long non-coding RNA ITGB2-AS1 in renal clear cell carcinoma
por: Zhou, Wei, et al.
Publicado: (2023)

Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses
por: Teixeira, Andre A, et al.
Publicado: (2017)

The oncogenic potentials and diagnostic significance of long non‐coding RNA LINC00310 in breast cancer
por: Li, Juan, et al.
Publicado: (2018)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Tumor Suppressive Maspin-Sensitized Prostate Cancer to Drug Treatment Through Negative Regulating Androgen Receptor Expression
por: Tang, Sijie, et al.
Publicado: (2020)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable Risk Men during Active Surveillance
por: Tosoian, Jeffrey J., et al.
Publicado: (2017)

An Efficient PCA-GA-HKSVM-Based Disease Diagnostic Assistant
por: Jerop, Brenda, et al.
Publicado: (2021)

Evaluation of Tissue PCA3 Expression in Prostate Cancer by RNA in situ Hybridization - A Correlative Study with Urine PCA3 and TMPRSS2-ERG
por: Warrick, Joshua I., et al.
Publicado: (2013)

Parameter estimation of the structured illumination pattern based on principal component analysis (PCA): PCA-SIM
por: Chen, Xin, et al.
Publicado: (2023)

Extraction of Prostatic Lumina and Automated Recognition for Prostatic Calculus Image Using PCA-SVM
por: Wang, Zhuocai, et al.
Publicado: (2011)

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015)

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
por: Newcomb, Lisa F., et al.
Publicado: (2019)

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
por: Saifuddin, S. R., et al.
Publicado: (2017)

Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status
por: Snider, Ashley J., et al.
Publicado: (2020)

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs
por: Bilal, Muhammad, et al.
Publicado: (2022)

Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells
por: Tang, Sijie, et al.
Publicado: (2021)

Improving RLRN Image Splicing Detection with the Use of PCA and Kernel PCA
por: Moghaddasi, Zahra, et al.
Publicado: (2014)

Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer
por: Yazarlou, Fatemeh, et al.
Publicado: (2018)

PEM-PCA: A Parallel Expectation-Maximization PCA Face Recognition Architecture
por: Rujirakul, Kanokmon, et al.
Publicado: (2014)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
por: Salagierski, Maciej, et al.
Publicado: (2010)

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA)
por: Gloi, Aime M, et al.
Publicado: (2013)

PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer
por: Tamposis, Ioannis, et al.
Publicado: (2022)

Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3
por: Takita, Sarra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1726jndbcp3h71pkjnb0f28tb